IceCure Medical Ltd (NasdaqCM: ICCM)
Health Care · Health Care Equipment & Supplies · IL
$1.09
-0.91% today · -95.8% 1Y
IceCure Medical Ltd (NasdaqCM: ICCM) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $5.10M and employs 68 people.
Over the last twelve months the share price has lost 95.8%, trading between 1.04 and 29.46.
Tweenvest scores IceCure Medical Ltd across four factors: quality 38/100, value 46/100, growth 27/100. Its strongest factor is value.
ICCM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.10M
- Revenue (TTM)
- $3.95M
- P/E
- —
- EPS
- -6.66
- Dividend yield
- —
- Beta (5Y)
- 0.43
- 52-week high
- $29.46
- 52-week low
- $1.04
- Avg volume (3M)
- —
- Shares outstanding
- 4.64M
- Employees
- 68
- Next earnings
- —
About IceCure Medical Ltd
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.
- ISIN
- IL0011224156
- Founded
- 2006
- Listed since
- Aug 26, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Clinical Laserthermia Systems AB (publ)OM: CLS B | $5.60M | Skr1.80 | +2.39% |
| Trinity Biotech plcNasdaqGS: TRIB | $5.57M | $6.86 | +13.49% |
| AJJ Medtech Holdings LimitedCatalist: 584 | $5.40M | S$0.00 | -20.00% |
| Immunovia AB (publ)OM: IMMNOV | $5.31M | Skr0.08 | -4.18% |
| Neola Medical AB (publ)OM: NEOLA | $5.02M | Skr0.45 | 0.00% |
| Surgical Innovations Group plcAIM: SUN | $4.94M | £0.00 | -5.88% |
| Cambridge Nutritional Sciences plcAIM: CNSL | $4.88M | £0.02 | +10.71% |
| StimCell Energetics Inc.OTCPK: STME | $4.80M | $0.23 | — |
Figures last refreshed Oct 11, 2026.